儿童喘发作预测的补充预测因素:唾液微生物群,血清炎症调解剂,以及过去的喘发作史
Shahriyar Shahbazi Khamas1,2,3, Paul Brinkman1,2,3, Anne H Neerincx1,2,3
1Amsterdam UMC Location University of Amsterdam, Department of Pulmonary Medicine, Amsterdam, the Netherlands.
Allergy
|August 18, 2025
概括
通过将病史与唾液微生物组和炎症标志物结合起来,可以更好地预测儿童未来的喘发作. 这种综合方法提高了早期风险识别和优化治疗策略的准确性.
科学领域:
- 儿科肺病学 儿科肺病学
- 微生物组研究 微生物组研究
- 免疫学 免疫学 免疫学
背景情况:
- 早期识别患喘发作风险的儿童对于有效治疗至关重要.
- 整合多样化的生物数据可以提高儿童喘恶化预测能力.
研究的目的:
- 开发一个全面的预测模型来预测儿童未来的喘发作.
- 评估唾液微生物组,血清炎症调解剂和喘病史的联合实用性.
主要方法:
- 这是一项两阶段研究 (发现和复制),涉及患有喘的学龄儿童.
- 随机森林模型使用历史喘发作,微生物组合和炎症媒介水平进行训练.
- 模型在独立数据集上得到验证,包括U-BIOPRED的子集.
主要成果:
- 结合过去喘发作,特定的唾液细菌 (Capnocytophaga,Corynebacterium, Cardiobacterium) 和炎症媒介 (TIMP-4,VEGF,MIP-3β) 的综合模型实现了最高的预测准确度 (AUROCC ~0.87).
- 仅基于过去的攻击,唾液细菌或炎症媒介的模型显示中等预测能力 (AUROCC ~ 0.7).
- 组合模型在复制阶段表现出强的性能 (AUROCC 0.84).
结论:
- 血清炎症调解剂和唾液微生物组数据在预测未来事件方面显著补充了喘发作史.
- 这些发现强调了调查口腔微生物群及其与免疫系统的相互作用,以预测喘的重要性.
相关概念视频
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:24Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
01:20Asthma: Pathogenesis and Management
581
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
581
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
453
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453